371 related articles for article (PubMed ID: 36612320)
21. Splicing regulatory factors in breast cancer hallmarks and disease progression.
Koedoot E; Wolters L; van de Water B; Dévédec SEL
Oncotarget; 2019 Oct; 10(57):6021-6037. PubMed ID: 31666932
[TBL] [Abstract][Full Text] [Related]
22. Updates of cancer hallmarks in patients with inborn errors of immunity.
Wang Y; Abolhassani H
Curr Opin Allergy Clin Immunol; 2022 Dec; 22(6):352-363. PubMed ID: 36165433
[TBL] [Abstract][Full Text] [Related]
23. Caregivers with Cancer Patients: Focus on Hispanics.
Bisht J; Rawat P; Sehar U; Reddy PH
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765585
[TBL] [Abstract][Full Text] [Related]
24. The PARP Enzyme Family and the Hallmarks of Cancer Part 1. Cell Intrinsic Hallmarks.
Demény MA; Virág L
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33922595
[TBL] [Abstract][Full Text] [Related]
25. CK2 and the Hallmarks of Cancer.
Firnau MB; Brieger A
Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009534
[TBL] [Abstract][Full Text] [Related]
26. The decalog of long non-coding RNA involvement in cancer diagnosis and monitoring.
Kunej T; Obsteter J; Pogacar Z; Horvat S; Calin GA
Crit Rev Clin Lab Sci; 2014 Dec; 51(6):344-57. PubMed ID: 25123609
[TBL] [Abstract][Full Text] [Related]
27. Aberrant sialylation in ovarian cancers.
Lee WL; Wang PH
J Chin Med Assoc; 2020 Apr; 83(4):337-344. PubMed ID: 31904658
[TBL] [Abstract][Full Text] [Related]
28. Fighting Carcinogenesis with Plant Metabolites by Weakening Proliferative Signaling and Disabling Replicative Immortality Networks of Rapidly Dividing and Invading Cancerous Cells.
Wani AK; Akhtar N; Sharma A; El-Zahaby SA
Curr Drug Deliv; 2023; 20(4):371-386. PubMed ID: 35422214
[TBL] [Abstract][Full Text] [Related]
29. The role of MicroRNAs in human cancer.
Peng Y; Croce CM
Signal Transduct Target Ther; 2016; 1():15004. PubMed ID: 29263891
[TBL] [Abstract][Full Text] [Related]
30. Signaling by Extracellular Vesicles Advances Cancer Hallmarks.
Kanada M; Bachmann MH; Contag CH
Trends Cancer; 2016 Feb; 2(2):84-94. PubMed ID: 28741553
[TBL] [Abstract][Full Text] [Related]
31. Melatonin and Cancer Hallmarks.
Talib WH
Molecules; 2018 Feb; 23(3):. PubMed ID: 29495398
[TBL] [Abstract][Full Text] [Related]
32. Exosomes, cancer's little army.
Al-Sowayan BS; Al-Shareeda AT; Al-Hujaily EM
Stem Cell Investig; 2019; 6():9. PubMed ID: 31119147
[TBL] [Abstract][Full Text] [Related]
33. Dissecting the molecular pathways involved in the effects of physical activity on breast cancers cells: A narrative review.
Orlandella FM; De Stefano AE; Iervolino PLC; Buono P; Soricelli A; Salvatore G
Life Sci; 2021 Jan; 265():118790. PubMed ID: 33220294
[TBL] [Abstract][Full Text] [Related]
34. In Vivo and Clinical Studies of Natural Products Targeting the Hallmarks of Cancer.
Elbadawi M; Efferth T
Handb Exp Pharmacol; 2024 May; ():. PubMed ID: 38797749
[TBL] [Abstract][Full Text] [Related]
35. Studies on heterocyclic compounds: 1,3-thiazolidin-4-one derivatives. IV. Biological activity of variously substituted 2,3-diaryl-1,3-thiazolidin-4-ones.
Piscopo E; Diurno MV; Gagliardi R; Mazzoni O; Veneruso G
Boll Soc Ital Biol Sper; 1989 Sep; 65(9):853-9. PubMed ID: 2627344
[TBL] [Abstract][Full Text] [Related]
36. PBX1: a key character of the hallmarks of cancer.
Veiga RN; de Oliveira JC; Gradia DF
J Mol Med (Berl); 2021 Dec; 99(12):1667-1680. PubMed ID: 34529123
[TBL] [Abstract][Full Text] [Related]
37. Cancer Hallmarks and MicroRNAs: The Therapeutic Connection.
Van Roosbroeck K; Calin GA
Adv Cancer Res; 2017; 135():119-149. PubMed ID: 28882220
[TBL] [Abstract][Full Text] [Related]
38. The Role of Extracellular Vesicles in the Hallmarks of Cancer and Drug Resistance.
Xavier CPR; Caires HR; Barbosa MAG; Bergantim R; Guimarães JE; Vasconcelos MH
Cells; 2020 May; 9(5):. PubMed ID: 32384712
[TBL] [Abstract][Full Text] [Related]
39. Sweetening the hallmarks of cancer: Galectins as multifunctional mediators of tumor progression.
Girotti MR; Salatino M; Dalotto-Moreno T; Rabinovich GA
J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31873723
[TBL] [Abstract][Full Text] [Related]
40. Nuclear morphometry, nucleomics and prostate cancer progression.
Veltri RW; Christudass CS; Isharwal S
Asian J Androl; 2012 May; 14(3):375-84. PubMed ID: 22504875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
